Gloved fingers hold a labeled vial of lenacapavir, a clear, yellowish liquid. Lenacapavir (shown) is an antiretroviral medication used to help prevent and treat HIV. Credit: Associated Press While ...
Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback. In 2022, the Food and Drug Administration (FDA), along with other health ...
A little over two decades ago, addressing Nigeria's HIV crisis topped U.S. President George W. Bush's priorities. Africa's most populous nation had 3.5 million HIV cases, and the disease threatened to ...
Limited provider awareness and capacity strains further complicate access, particularly in primary care and rural settings.
National initiative will connect patients directly to prevention and treatment while offering states a new model for long-term HIV care at no cost to the state or patient ...
Al Jazeera on MSN
HIV prevention drug hailed as breakthrough, but who gets access?
Lenacapavir, a twice-a-year injection could transform HIV prevention, but it will not be available to all.
The FDA has approved Gilead's once-daily HIV pill, Bixlenvo, designed to simplify treatment for patients with controlled virus and streamline complex regimens.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results